Clinical trials data
Stroop Color-Word Test in dementia and Alzheimer's trials: 116 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names the Stroop Color-Word Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 116
- Name it in a primary outcome, 42%
- 49 of 116
Tests named in the same studies
- 1
Trail Making Test63 studies, 24 as a primary outcome
- 2
Verbal Fluency40 studies, 20 as a primary outcome
- 3
Digit Span Test39 studies, 13 as a primary outcome
- 4
Verbal Learning32 studies, 18 as a primary outcome
- 5
Symbol Coding23 studies, 10 as a primary outcome
- 6
Category Fluency19 studies, 8 as a primary outcome
- 7
Short Story Recall19 studies, 7 as a primary outcome
- 8
Complex Figure Copy and Recall18 studies, 10 as a primary outcome
- 9
Selective Reminding Task14 studies, 7 as a primary outcome
- 10
Picture Naming Test13 studies, 7 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 1 |
| 2005 | 2 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 5 | 2 |
| 2011 | 4 | 1 |
| 2012 | 3 | 2 |
| 2013 | 0 | 0 |
| 2014 | 3 | 0 |
| 2015 | 4 | 2 |
| 2016 | 7 | 1 |
| 2017 | 6 | 2 |
| 2018 | 7 | 3 |
| 2019 | 9 | 6 |
| 2020 | 6 | 3 |
| 2021 | 9 | 4 |
| 2022 | 10 | 6 |
| 2023 | 7 | 3 |
| 2024 | 9 | 4 |
| 2025 | 10 | 4 |
| 2026 | 10 | 2 |
Phases and study sizes
By phase
- Early phase 12 studies, 2 as a primary outcome
- Phase 1/23 studies, 2 as a primary outcome
- Phase 213 studies, 4 as a primary outcome
- Phase 2/32 studies, 1 as a primary outcome
- Phase 31 studies, 0 as a primary outcome
- Phase 44 studies, 1 as a primary outcome
- Not applicable70 studies, 27 as a primary outcome
- Observational21 studies, 12 as a primary outcome
Participants per study
- Phase 255 median, 34 to 80
- Not applicable60 median, 40 to 140
- Observational120 median, 78 to 275
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 13 | 55 | 34 to 80 |
| Not applicable | 68 | 60 | 40 to 140 |
| Observational | 20 | 120 | 78 to 275 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day15 outcomes, 10 as a primary outcome
- Up to 4 weeks12 outcomes, 6 as a primary outcome
- 1 to 3 months27 outcomes, 12 as a primary outcome
- 3 to 6 months21 outcomes, 7 as a primary outcome
- 6 to 12 months22 outcomes, 5 as a primary outcome
- 1 to 2 years8 outcomes, 3 as a primary outcome
- Over 2 years6 outcomes, 4 as a primary outcome
- No duration given5 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
111 of the 116 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting17 studies, 5 as a primary outcome
- Not yet recruiting7 studies, 3 as a primary outcome
- Active, not recruiting4 studies, 2 as a primary outcome
- Completed55 studies, 26 as a primary outcome
- Stopped early6 studies, 3 as a primary outcome
- Status unknown27 studies, 10 as a primary outcome
What they test
- Behavioral39 studies, 19 as a primary outcome
- Drug18 studies, 7 as a primary outcome
- Device26 studies, 9 as a primary outcome
- Dietary supplement7 studies, 2 as a primary outcome
- Procedure4 studies, 0 as a primary outcome
- Diagnostic test5 studies, 2 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Other27 studies, 9 as a primary outcome
- None given10 studies, 7 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States38 studies, 20 as a primary outcome
- Italy17 studies, 6 as a primary outcome
- China10 studies, 2 as a primary outcome
- Spain7 studies, 4 as a primary outcome
- Canada6 studies, 0 as a primary outcome
- Taiwan5 studies, 5 as a primary outcome
- France4 studies, 1 as a primary outcome
- Germany4 studies, 0 as a primary outcome
- Netherlands4 studies, 0 as a primary outcome
- United Kingdom4 studies, 1 as a primary outcome
- Brazil3 studies, 0 as a primary outcome
- South Korea3 studies, 1 as a primary outcome
35 countries in all. A study with sites in several counts in each; 6 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name the Stroop Color-Word Test: 30 of 55, 55%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name the Stroop Color-Word Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 10, 18% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 13% | 1,139, 14% |
| A results paper only | 13, 24% | 1,711, 22% |
| Neither | 25, 45% | 4,327, 54% |
The 116 studies
116 studies match. 49 name the Stroop Color-Word Test in a primary outcome. Median size 68 participants. Median time to the primary outcome: 9 weeks.
Loading 116 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 1 |
| 2005 | 2 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 5 | 2 |
| 2011 | 4 | 1 |
| 2012 | 3 | 2 |
| 2013 | 0 | 0 |
| 2014 | 3 | 0 |
| 2015 | 4 | 2 |
| 2016 | 7 | 1 |
| 2017 | 6 | 2 |
| 2018 | 7 | 3 |
| 2019 | 9 | 6 |
| 2020 | 6 | 3 |
| 2021 | 9 | 4 |
| 2022 | 10 | 6 |
| 2023 | 7 | 3 |
| 2024 | 9 | 4 |
| 2025 | 10 | 4 |
| 2026 | 10 | 2 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 4, other 112. Interventional 95, observational 21.
As a primary outcomeSecondary or other outcomeThe Stroop Color-Word Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07882251 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07730671 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants121 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07692542 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07646054 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07533084 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Aging, frailty and exercise | Participants265 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07399418 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07364019 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants700 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07163039 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants60 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07149038 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants24 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07138677 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07036328 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants55 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07033481 | Start2025 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants20 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07033468 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07025070 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06875739 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Parkinson's disease | Participants310 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06869135 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease | Participants242 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06797817 | Start2026 | PhasePhase 3 | ConditionsDementia and Alzheimer's | Participants156 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06734546 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Obesity and diabetes | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06668610 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06595511 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06588946 | Start2025 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use the Stroop Color-Word Test?
116 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 49 of them in a primary outcome: 7% of the condition's 1,673 studies with a cognitive outcome, against 12% of all of them. It is the 7th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with the Stroop Color-Word Test?
The Trail Making Test (63 studies), Verbal Fluency (40 studies) and the Digit Span Test (39 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use the Stroop Color-Word Test enroll?
Half of the phase 2 studies that name it enroll 55 participants or fewer, and the middle half enroll 34 to 80. 13 of them give a size.
When do dementia and Alzheimer's trials measure the Stroop Color-Word Test?
Half of the primary outcomes that name the Stroop Color-Word Test are measured within 9 weeks of the start, and the middle half from 1 week to 7 months. 47 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use the Stroop Color-Word Test have reported results?
30 of the 55 completed studies that name it, 55%, have reported results: 17 posted them on ClinicalTrials.gov, 23 have a results paper linked to the registry record, and 10 did both. The other 25 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Stroop Color-Word Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.